WHO Analgesic Ladder (Modified)
Start at the step that matches the patient's pain severity. You do NOT have to climb from Step 1 โ 2 โ 3 sequentially. A patient with severe post-op pain can start at Step 3 immediately. Add adjuvants at EVERY step.
Step 1 -Mild Pain (1โ3/10)
Non-opioid analgesics:
โข
Acetaminophen (Tylenol) 650โ1000 mg PO q6h (max 3g/day if liver disease, 4g if healthy)
โข
Ibuprofen (Advil) 400โ600 mg PO q6h with food
โข
Ketorolac (Toradol) 15โ30 mg IV q6h (max 5 days -renal/GI risk)
โข
Celecoxib (Celebrex) 200 mg PO BID (lower GI bleed risk)
โ ๏ธ NSAIDs: avoid in CKD (GFR < 30), active GI bleed, HF, post-CABG, concurrent anticoagulation, platelets < 50K
Step 2 -Moderate Pain (4โ6/10)
Weak opioids ยฑ non-opioids:
โข
Tramadol (Ultram) 50โ100 mg PO q6h (max 400 mg/day)
โข
Hydrocodone/APAP (Norco) 5/325 -1-2 tabs q4-6h
โข
Oxycodone IR (OxyContin) 5 mg PO q4-6h PRN
โข Continue scheduled acetaminophen + NSAIDs if safe
โ ๏ธ Tramadol: seizure risk, serotonin syndrome with SSRIs/SNRIs, avoid in epilepsy
Step 3 -Severe Pain (7โ10/10)
Strong opioids ยฑ non-opioids:
โข
Morphine (MS Contin) 2โ4 mg IV q3-4h PRN
โข
Hydromorphone (Dilaudid) 0.5โ1 mg IV q3-4h PRN
โข
Fentanyl (Sublimaze) 25โ50 mcg IV q1-2h (short duration)
โข
Oxycodone 5โ10 mg PO q4h
โข Continue non-opioid adjuncts (multimodal)
โ ๏ธ Always start bowel regimen with opioids (PEG 3350 + senna). No ceiling for opioid dose in cancer/palliative pain.
Adjuvant Analgesics -Add at ANY Step
| Drug | MOA | Dose | Best For | โ ๏ธ Side Effects |
| Gabapentin (Neurontin) | Calcium channel ฮฑ2ฮด ligand -reduces excitatory neurotransmitter release | 100โ300 mg PO TID, titrate to 900โ3600 mg/day | Neuropathic pain (diabetic neuropathy, post-herpetic neuralgia, radiculopathy) | โ ๏ธ Sedation, dizziness, peripheral edema. Renally cleared -reduce dose in CKD. |
| Pregabalin (Lyrica) | Same as gabapentin, higher affinity, more predictable (linear) absorption. ~6× more potent than gabapentin (300 mg gabapentin ≈ 50 mg pregabalin), so dose numbers are smaller. | 75 mg PO BID → max 300 mg BID | Neuropathic pain, fibromyalgia | โ ๏ธ Same as gabapentin. Schedule V controlled substance (abuse potential). |
| Duloxetine (Cymbalta) | SNRI -inhibits serotonin + norepinephrine reuptake in descending pain pathways | 30 mg PO daily ร 1 week โ 60 mg daily | Diabetic neuropathy, musculoskeletal pain, fibromyalgia | โ ๏ธ Nausea (take with food), serotonin syndrome risk with tramadol/other serotonergics. Do NOT stop abruptly. |
| Dexamethasone (Decadron) | Glucocorticoid -reduces peritumoral edema and inflammation | 4โ8 mg IV/PO daily | Bone metastases, spinal cord compression, bowel obstruction, cerebral edema | โ ๏ธ Hyperglycemia, insomnia, GI upset, immunosuppression. Short-term use preferred. |
| Lidocaine patch (5%) | Sodium channel blockade -local anesthetic | 1โ3 patches to painful area, 12h on / 12h off | Localized neuropathic pain, post-herpetic neuralgia, musculoskeletal | โ ๏ธ Minimal systemic absorption. Skin irritation at site. |
| Ketamine (low-dose) | NMDA receptor antagonist -blocks central sensitization | 0.1โ0.3 mg/kg/hr IV infusion | Opioid-refractory pain, chronic pain crises, sickle cell VOC | โ ๏ธ Dissociation, hallucinations, nausea, โ secretions. Avoid in psychosis, elevated ICP. |
| Muscle relaxants | Various -central acting (tizanidine, cyclobenzaprine, baclofen) | Tizanidine 2โ4 mg TID, Cyclobenzaprine 5โ10 mg TID, Baclofen 5โ10 mg TID | Musculoskeletal spasm, back pain | โ ๏ธ Sedation (all), hepatotoxicity (tizanidine), anticholinergic (cyclobenzaprine). Baclofen withdrawal can cause seizures. |
PCA (Patient-Controlled Analgesia) Dosing
PCA is for patients who can self-dose -must be alert, understand the button, and have no cognitive impairment. Family members should NEVER press the PCA button (risk of oversedation/respiratory arrest).
| Opioid | Demand Dose | Lockout | Basal Rate (if needed) | 1-hour Limit | Notes |
| Morphine PCA | 1โ2 mg | 6โ10 min | 0โ1 mg/hr (avoid in opioid-naive) | 10 mg | Standard first-line PCA. Avoid in renal failure (M6G accumulation). |
| Hydromorphone PCA | 0.2โ0.4 mg | 6โ10 min | 0โ0.2 mg/hr | 2 mg | Preferred in renal impairment. ~5โ7ร more potent than morphine IV. |
| Fentanyl PCA | 10โ25 mcg | 6โ10 min | 0โ25 mcg/hr | 150 mcg | Short acting. Good for procedure-related pain. Lipophilic -accumulates with prolonged use. |
โ ๏ธ Basal rate + PCA in opioid-naive patients = dangerous. A continuous basal rate removes the safety net of the PCA system (patient stops pressing button when sedated). Use demand-only dosing for opioid-naive patients. Basal rate only for opioid-tolerant patients with established requirements.
IV โ PO Opioid Conversion -When to Switch
- Switch IV โ PO when: patient tolerating PO intake, pain controlled โฅ 24h on stable IV dose, no nausea/vomiting
- How: Calculate total 24h IV morphine equivalents โ convert to PO using equianalgesic table โ reduce by 25% for cross-tolerance โ split into scheduled + PRN
- Example: Patient on morphine PCA using 30 mg IV/24h โ PO equivalent = 30 ร 3 = 90 mg PO morphine/day โ reduce 25% = ~68 mg โ split: oxycodone ER 30 mg PO BID (60 mg/day) + oxycodone IR 5โ10 mg q4h PRN for breakthrough
- PRN breakthrough dose: 10โ15% of total daily dose given q3-4h PRN
Multimodal Analgesia -The Modern Approach
Multimodal = combine drugs from different classes to target different pain pathways. This reduces opioid requirements by 30โ50%, lowers side effects, and improves pain control. Every patient should get scheduled acetaminophen + NSAID (if safe) BEFORE reaching for opioids.
| Pain Type | Recommended Multimodal Regimen |
| Post-surgical | Scheduled APAP 1g q6h + ketorolac 15 mg IV q6h (โค 5 days) + gabapentin 300 mg preop + opioid PRN. Consider regional/nerve block. |
| Neuropathic | Gabapentin/pregabalin + duloxetine + lidocaine patch. Opioids are second-line (less effective for neuropathic pain). |
| Cancer / bone mets | Scheduled long-acting opioid + APAP + dexamethasone 4โ8 mg + radiation therapy referral. Bisphosphonates for widespread bone mets. |
| Sickle cell VOC | IV morphine/hydromorphone PCA + scheduled APAP + ketorolac (โค 5 days) + low-dose ketamine if refractory. NSAIDs safe short-term if GFR ok. |
| Chronic non-cancer | Maximize non-opioid: APAP, NSAIDs, duloxetine, gabapentin, PT/CBT. Opioids are last resort -risks of dependence, hyperalgesia. |
| Palliative / end-of-life | Scheduled opioid (no ceiling) + PRN breakthrough + adjuvants. Titrate to comfort. Address total pain (physical, emotional, spiritual). |
Tiered PRN Pain Order Set -What to Write on Admission
Write pain orders in 3 tiers so the nurse can choose based on the patient's assessed pain level -without paging you for every dose. The nurse uses NRS (0โ10) for alert patients or CPOT (0โ8) for intubated/non-verbal patients to select the right tier.
Alert Patients -Numeric Rating Scale (NRS 0โ10)
| Pain Level | NRS Score | Medication | Dose | Route | Frequency |
| Mild | 1โ3 | Acetaminophen (Tylenol) | 650โ1000 mg | PO | q6h PRN |
| Moderate | 4โ6 | Oxycodone IR (OxyContin) | 5 mg | PO | q4h PRN |
| Moderate | 4โ6 | Alternative: Tramadol (Ultram) | 50 mg | PO | q6h PRN |
| Severe | 7โ10 | Hydromorphone (Dilaudid) | 0.5โ1 mg | IV | q3h PRN |
| Severe | 7โ10 | Alternative: Morphine (MS Contin) | 2โ4 mg | IV | q3-4h PRN |
โ ๏ธ Adjust for special populations:
โข Elderly / CKD / hepatic: Start at lower end of each tier (oxycodone 2.5 mg, hydromorphone 0.25 mg)
โข Opioid-tolerant: May need higher doses at each tier
โข Post-surgical: Add scheduled APAP 1g q6h + ketorolac 15 mg IV q6h (multimodal reduces opioid need by 30โ50%)
Intubated / Non-Verbal Patients -CPOT Score (0โ8)
| Domain | 0 Points | 1 Point | 2 Points |
| Facial expression | Relaxed, neutral | Tense (brow furrowed, orbit tightened) | Grimacing (teeth clenching, deep furrows) |
| Body movements | Absent, normal position | Protection (slow, cautious, touching pain site) | Restlessness (pulling at tubes, attempting to sit up, thrashing) |
| Compliance with ventilator (intubated) or Vocalization (extubated) | Tolerating vent / talking normally | Coughing but tolerating / sighing, moaning | Fighting vent, triggering alarms / crying out, sobbing |
| Muscle tension (passive flexion/extension of upper extremity) | Relaxed, no resistance | Resistance to passive movements | Strong resistance, unable to complete movement |
| Pain Level | CPOT Score | Medication | Dose | Route | Frequency |
| Minimal | 0โ2 | Acetaminophen (Tylenol) | 1000 mg | IV | q6h PRN |
| Moderate | 3โ4 | Fentanyl (Sublimaze) | 25 mcg | IV | q2h PRN |
| Significant | 5โ8 | Fentanyl (Sublimaze) | 50โ100 mcg | IV | q1-2h PRN |
| Significant | 5โ8 | Alternative: Hydromorphone (Dilaudid) | 0.5 mg | IV | q3h PRN |
โ ๏ธ CPOT โฅ 3 = significant pain -treat it. Intubated patients cannot tell you they hurt. Studies show ICU patients experience moderate-to-severe pain during routine care (turning, suctioning, wound care). Undertreated pain increases delirium, prolongs ventilation, and causes PTSD.
โ ๏ธ Always reassess within 30 minutes of giving PRN pain medication. If CPOT or NRS unchanged โ escalate to next tier or consider continuous infusion. Document pre- and post-intervention pain scores.